Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
2020 · Kidney International · 500 citations
https://doi.org/10.1016/j.kint.2020.09.006
J
Julia Kerschbaum
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
3.0K
Citations
27
h-index
46
i10-index
Julia Kerschbaum is an academic researcher from Statistics Austria. The author has contributed to research in topics: Dialysis and Renal Disease Management & Chronic Kidney Disease and Diabetes & Renal Transplantation Outcomes and Treatments. The author has an h-index of 27, co-authored 66 publications.
ORCID: 0000-0002-6896-2279Papers by this author
worksCOVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
2020 · Nephrology Dialysis Transplantation · 409 citations
https://doi.org/10.1093/ndt/gfaa261
Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
2018 · Annals of the Rheumatic Diseases · 144 citations
https://doi.org/10.1136/annrheumdis-2017-212861
Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in Europe
2021 · Kidney International · 53 citations
https://doi.org/10.1016/j.kint.2020.12.010
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
2022 · Nephrology Dialysis Transplantation · 15 citations
https://doi.org/10.1093/ndt/gfac008
Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular Profiles
2019 · Computational and Structural Biotechnology Journal · 14 citations
https://doi.org/10.1016/j.csbj.2019.06.019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat